HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clonidine for the treatment of supine hypertension and pressure natriuresis in autonomic failure.

Abstract
Patients with autonomic failure are disabled by orthostatic hypotension, which can be worsened by the nighttime pressure natriuresis induced by associated supine hypertension. Several pharmacological agents are available that effectively reduce nighttime hypertension, but none of them prevent pressure natriuresis. Because hypertension of autonomic failure can be driven by residual sympathetic tone, we hypothesized that clonidine would be effective in reducing blood pressure (BP) and nocturnal natriuresis. Therefore, we determined the effect of placebo, 0.1 mg clonidine, and 0.1-mg/h nitroglycerin transdermal patch on supine BP, orthostatic hypotension, and pressure natriuresis in 23 patients with primary autonomic failure and supine hypertension. Medications were given at 8:00 PM, and BP was recorded every 2 hours for 12 hours. The maximal decrease in BP was seen 6 to 8 hours after drug administration and was similar to clonidine and nitroglycerin (-29+/-9 and -30+/-10 mm Hg, respectively), as was the average fall in BP throughout the night. However, only clonidine effectively reduced nocturnal natriuresis (-0.09 mmol/mg Cr; 95% CI, -0.13 to -0.04; P=0.004), but this was not associated with improvement in morning orthostatic hypotension because of a residual hypotensive effect. The decrease in BP induced by clonidine was modestly but significantly correlated with the magnitude of residual sympathetic tone determined in 10 subjects by the fall in BP induced by ganglionic blockade (r=0.66; P=0.043). These results are consistent with residual sympathetic tone contributing to supine hypertension in autonomic failure, which can be targeted with clonidine to decrease BP and nocturnal natriuresis.
AuthorsCyndya Shibao, Alfredo Gamboa, Robert Abraham, Satish R Raj, Andre Diedrich, Bonnie Black, David Robertson, Italo Biaggioni
JournalHypertension (Dallas, Tex. : 1979) (Hypertension) Vol. 47 Issue 3 Pg. 522-6 (Mar 2006) ISSN: 1524-4563 [Electronic] United States
PMID16391172 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antihypertensive Agents
  • Sympatholytics
  • Vasodilator Agents
  • Nitroglycerin
  • Clonidine
Topics
  • Aged
  • Aged, 80 and over
  • Antihypertensive Agents (therapeutic use)
  • Autonomic Nervous System (physiopathology)
  • Autonomic Nervous System Diseases (complications, physiopathology)
  • Blood Pressure (drug effects)
  • Clonidine (therapeutic use)
  • Female
  • Humans
  • Hypertension (drug therapy, etiology, physiopathology)
  • Hypotension, Orthostatic (etiology, physiopathology)
  • Male
  • Middle Aged
  • Natriuresis (drug effects)
  • Nitroglycerin (therapeutic use)
  • Supine Position
  • Sympathetic Nervous System (drug effects, physiopathology)
  • Sympatholytics (therapeutic use)
  • Vasodilator Agents (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: